Osteoblasts Express NLRP3, a Nucleotide-Binding Domain and Leucine-Rich Repeat Region Containing Receptor Implicated in Bacterially Induced Cell Death
- 1 January 2008
- journal article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 23 (1) , 30-40
- https://doi.org/10.1359/jbmr.071002
Abstract
Bacterially induced osteoblast apoptosis may be a major contributor to bone loss during osteomyelitis. We provide evidence for the functional expression in osteoblasts of NLRP3, a member of the NLR family of cytosolic receptors that has been implicated in the initiation of programmed cell death. Osteoblasts undergo apoptosis after exposure to intracellular bacterial pathogens commonly associated with osteomyelitis. Death of this bone-forming cell type, in conjunction with increased numbers and activity of osteoclasts, may underlie the destruction of bone tissue at sites of bacterial infection. To date, the mechanisms responsible for bacterially induced apoptotic osteoblast cell death have not been resolved. We used flow cytometric techniques to determine whether intracellular invasion is needed for maximal apoptotic cell death in primary osteoblasts after challenge with Salmonella enterica. In addition, we used real-time PCR and immunoblot analyses to assess osteoblast expression of members of the nucleotide-binding domain leucine-rich repeat region-containing family of intracellular receptors (NLRs) that have been predicted to be involved in the induction of programmed cell death. Furthermore, we have used co-immunoprecipitation and siRNA techniques to confirm the functionality of such sensors in this cell type. In this study, we showed that invasion of osteoblasts by Salmonella is necessary for maximal induction of apoptosis. We showed that murine and human osteoblasts express NLRP3 (previously known as CIAS1, cryopyrin, PYPAF1, or NALP3) but not NLRC4 (IPAF) and showed that the level of expression of this cytosolic receptor is modulated after bacterial challenge. We showed that osteoblasts express ASC, an adaptor molecule for NLRP3, and that these molecules associate after Salmonella infection. In addition, we showed that a reduction in the expression of NLRP3 attenuates Salmonella-induced reductions in the activity of an anti-apoptotic transcription factor in osteoblasts. Furthermore, we showed that NLRP3 expression is needed for caspase-1 activation and maximal induction of apoptosis in osteoblasts after infection with Salmonella. The functional expression of NLRP3 in osteoblasts provides a potential mechanism underlying apoptotic cell death of this cell type after challenge with intracellular bacterial pathogens and may be a significant contributory factor to bone loss at sites of infection.Keywords
This publication has 52 references indexed in Scilit:
- Role of macrophages in LPS-induced osteoblast and PDL cell apoptosisBone, 2006
- Cryopyrin activates the inflammasome in response to toxins and ATPNature, 2006
- Structural, expression, and evolutionary analysis of mouse CIAS1Gene, 2004
- Signaling via Toll-Like Receptor 5 Can Initiate Inflammatory Mediator Production by Murine OsteoblastsInfection and Immunity, 2003
- NODs: intracellular proteins involved in inflammation and apoptosisNature Reviews Immunology, 2003
- Functional CD40 Expression Induced following Bacterial Infection of Mouse and Human OsteoblastsInfection and Immunity, 2003
- Nuclear Factor-κB-inducible Death Effector Domain-containing Protein Suppresses Tumor Necrosis Factor-mediated Apoptosis by Inhibiting Caspase-8 ActivityJournal of Biological Chemistry, 2001
- Monocyte Chemoattractant Protein-1 Expression by Osteoblasts Following Infection withStaphylococcus aureusorSalmonellaJournal of Interferon & Cytokine Research, 2001
- Staphylococcus aureusandSalmonella entericaSerovar Dublin Induce Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Expression by Normal Mouse and Human OsteoblastsInfection and Immunity, 2001
- Emergence of ciprofloxacin resistance during treatment of salmonella osteomyelitis in three patients with sickle cell diseaseJournal of Infection, 1996